{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T05:46:09Z","timestamp":1790660769450,"version":"4.1.0"},"reference-count":60,"publisher":"Japanese Circulation Society","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Circ J"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1253\/circj.cj-18-0063","type":"journal-article","created":{"date-parts":[[2018,2,6]],"date-time":"2018-02-06T22:10:27Z","timestamp":1517955027000},"page":"629-635","source":"Crossref","is-referenced-by-count":113,"title":["Inflammatory Mechanisms of Cardiovascular Remodeling"],"prefix":"10.1253","volume":"82","author":[{"given":"Toshihisa","family":"Anzai","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"330","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Anzai T, Yoshikawa T, Shiraki H, Asakura Y, Akaishi M, Mitamura H, et al. C-reactive protein as a predictor of infarct expansion and cardiac rupture after a first Q-wave acute myocardial infarction. <i>Circulation<\/i> 1997; 96: 778\u2013784.","DOI":"10.1161\/01.CIR.96.3.778"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. <i>Circulation<\/i> 2001; 104: 365\u2013372.","DOI":"10.1161\/01.CIR.104.3.365"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Varnava AM, Mills PG, Davies MJ. Relationship between coronary artery remodeling and plaque vulnerability. <i>Circulation<\/i> 2002; 105: 939\u2013943.","DOI":"10.1161\/hc0802.104327"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Kaneko H, Anzai T, Takahashi T, Kohno T, Shimoda M, Sasaki A, et al. Role of vascular endothelial growth factor-A in development of abdominal aortic aneurysm. <i>Cardiovasc Res<\/i> 2011; 91: 358\u2013367.","DOI":"10.1093\/cvr\/cvr080"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Anzai T, Yoshikawa T, Asakura Y, Abe S, Meguro T, Akaishi M, et al. Effect on short-term prognosis and left ventricular function of angina pectoris prior to first Q-wave anterior wall acute myocardial infarction. <i>Am J Cardiol<\/i> 1994; 74: 755\u2013759.","DOI":"10.1016\/0002-9149(94)90428-6"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Anzai T, Yoshikawa T, Asakura Y, Abe S, Akaishi M, Mitamura H, et al. Preinfarction angina as a major predictor of left ventricular function and long-term prognosis after a first Q wave myocardial infarction. <i>J Am Coll Cardiol<\/i> 1995; 26: 319\u2013327.","DOI":"10.1016\/0735-1097(95)80002-X"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Shiraki H, Yoshikawa T, Anzai T, Negishi K, Takahashi T, Asakura Y, et al. Association between preinfarction angina and a lower risk of right ventricular infarction. <i>N Engl J Med<\/i> 1998; 338: 941\u2013947.","DOI":"10.1056\/NEJM199804023381402"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Falk E, Shah PK, Fuster V. Coronary plaque disruption. <i>Circulation<\/i> 1995; 92: 657\u2013671.","DOI":"10.1161\/01.CIR.92.3.657"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Shah PK. Mechanisms of plaque vulnerability and rupture. <i>J Am Coll Cardiol<\/i> 2003; 41: 15S\u201322S.","DOI":"10.1016\/S0735-1097(02)02834-6"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. <i>Circulation<\/i> 1999; 99: 237\u2013242.","DOI":"10.1161\/01.CIR.99.2.237"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. <i>N Engl J Med<\/i> 2000; 342: 836\u2013843.","DOI":"10.1056\/NEJM200003233421202"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: A comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. <i>JAMA<\/i> 2001; 285: 2481\u20132485.","DOI":"10.1001\/jama.285.19.2481"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. <i>N Engl J Med<\/i> 2002; 347: 1557\u20131565.","DOI":"10.1056\/NEJMoa021993"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: An 8-year follow-up of 14,719 initially healthy American women. <i>Circulation<\/i> 2003; 107: 391\u2013397.","DOI":"10.1161\/01.CIR.0000055014.62083.05"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Ridker PM. High-sensitivity C-reactive protein and cardiovascular risk: Rationale for screening and primary prevention. <i>Am J Cardiol<\/i> 2003; 92: 17K\u201322K.","DOI":"10.1016\/S0002-9149(03)00774-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Goicoechea M, de Vinuesa SG, Lahera V, Cachofeiro V, Gomez-Campdera F, Vega A, et al. Effects of atorvastatin on inflammatory and fibrinolytic parameters in patients with chronic kidney disease. <i>J Am Soc Nephrol<\/i> 2006; 17: S231\u2013S235.","DOI":"10.1681\/ASN.2006080938"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Staszewsky L, Wong M, Masson S, Barlera S, Carretta E, Maggioni AP, et al. Clinical, neurohormonal, and inflammatory markers and overall prognostic role of chronic obstructive pulmonary disease in patients with heart failure: Data from the Val-HeFT heart failure trial. <i>J Card Fail<\/i> 2007; 13: 797\u2013804.","DOI":"10.1016\/j.cardfail.2007.07.012"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events (CARE) Investigators. <i>Circulation<\/i> 1998; 98: 839\u2013844.","DOI":"10.1161\/01.CIR.98.9.839"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM Jr, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. <i>N Engl J Med<\/i> 2008; 359: 2195\u20132207.","DOI":"10.1056\/NEJMoa0807646"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. <i>N Engl J Med<\/i> 1997; 336: 973\u2013979.","DOI":"10.1056\/NEJM199704033361401"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Lindahl B, Toss H, Siegbahn A, Venge P, Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. <i>N Engl J Med<\/i> 2000; 343: 1139\u20131147.","DOI":"10.1056\/NEJM200010193431602"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Walter DH, Fichtlscherer S, Sellwig M, Auch-Schwelk W, Schachinger V, Zeiher AM. Preprocedural C-reactive protein levels and cardiovascular events after coronary stent implantation. <i>J Am Coll Cardiol<\/i> 2001; 37: 839\u2013846.","DOI":"10.1016\/S0735-1097(00)01193-1"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Ridker PM, Everett BM, Thuren T, MacFadyen JG, Chang WH, Ballantyne C, et al. Antiinflammatory therapy with canakinumab for atherosclerotic disease. <i>N Engl J Med<\/i> 2017; 377: 1119\u20131131.","DOI":"10.1056\/NEJMoa1707914"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pfeffer MA, Braunwald E. Ventricular remodeling after myocardial infarction: Experimental observations and clinical implications. <i>Circulation<\/i> 1990; 81: 1161\u20131172.","DOI":"10.1161\/01.CIR.81.4.1161"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Takahashi T, Anzai T, Yoshikawa T, Maekawa Y, Asakura Y, Satoh T, et al. Serum C-reactive protein elevation in left ventricular remodeling after acute myocardial infarction: Role of neurohormones and cytokines. <i>Int J Cardiol<\/i> 2003; 88: 257\u2013265.","DOI":"10.1016\/S0167-5273(02)00416-3"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Anzai T, Yoshikawa T, Takahashi T, Maekawa Y, Okabe T, Asakura Y, et al. Early use of beta-blockers is associated with attenuation of serum C-reactive protein elevation and favorable short-term prognosis after acute myocardial infarction. <i>Cardiology<\/i> 2003; 99: 47\u201353.","DOI":"10.1159\/000068449"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Mahara K, Anzai T, Yoshikawa T, Maekawa Y, Okabe T, Asakura Y, et al. Aging adversely affects postinfarction inflammatory response and early left ventricular remodeling after reperfused acute anterior myocardial infarction. <i>Cardiology<\/i> 2006; 105: 67\u201374.","DOI":"10.1159\/000089542"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Naito K, Anzai T, Yoshikawa T, Anzai A, Kaneko H, Kohno T, et al. Impact of chronic kidney disease on postinfarction inflammation, oxidative stress, and left ventricular remodeling. <i>J Card Fail<\/i> 2008; 14: 831\u2013838.","DOI":"10.1016\/j.cardfail.2008.07.233"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Maekawa Y, Anzai T, Yoshikawa T, Asakura Y, Takahashi T, Ishikawa S, et al. Prognostic significance of peripheral monocytosis after reperfused acute myocardial infarction: A possible role for left ventricular remodeling. <i>J Am Coll Cardiol<\/i> 2002; 39: 241\u2013246.","DOI":"10.1016\/S0735-1097(01)01721-1"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Maekawa Y, Anzai T, Yoshikawa T, Sugano Y, Mahara K, Kohno T, et al. Effect of granulocyte-macrophage colony-stimulating factor inducer on left ventricular remodeling after acute myocardial infarction. <i>J Am Coll Cardiol<\/i> 2004; 44: 1510\u20131520.","DOI":"10.1016\/j.jacc.2004.05.083"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Silverman HF, Pfeifer MP. Relation between use of anti-inflammatory agents in left ventricular free wall rupture during acute myocardial infarction. <i>Am J Cardiol<\/i> 1987; 59: 363\u2013364.","DOI":"10.1016\/0002-9149(87)90817-4"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Anzai T. Post-infarction inflammation and left ventricular remodeling: A double-edged sword. <i>Circ J<\/i> 2013; 77: 580\u2013587.","DOI":"10.1253\/circj.CJ-13-0013"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33. Kohno T, Anzai T, Naito K, Miyasho T, Okamoto M, Yokota H, et al. Role of high-mobility group box 1 protein in post-infarction healing process and left ventricular remodelling. <i>Cardiovasc Res<\/i> 2009; 81: 565\u2013573.","DOI":"10.1093\/cvr\/cvn291"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Naito K, Anzai T, Sugano Y, Maekawa Y, Kohno T, Yoshikawa T, et al. Differential effects of GM-CSF and G-CSF on infiltration of dendritic cells during early left ventricular remodeling after myocardial infarction. <i>J Immunol<\/i> 2008; 181: 5691\u20135701.","DOI":"10.4049\/jimmunol.181.8.5691"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Anzai A, Anzai T, Nagai S, Maekawa Y, Naito K, Kaneko H, et al. Regulatory role of dendritic cells in postinfarction healing and left ventricular remodeling. <i>Circulation<\/i> 2012; 125: 1234\u20131245.","DOI":"10.1161\/CIRCULATIONAHA.111.052126"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Bamboat ZM, Ocuin LM, Balachandran VP, Obaid H, Plitas G, DeMatteo RP. Conventional DCs reduce liver ischemia\/reperfusion injury in mice via IL-10 secretion. <i>J Clin Invest<\/i> 2010; 120: 559\u2013569.","DOI":"10.1172\/JCI40008"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Nagai T, Honda S, Sugano Y, Matsuyama TA, Ohta-Ogo K, Asaumi Y, et al. Decreased myocardial dendritic cells is associated with impaired reparative fibrosis and development of cardiac rupture after myocardial infarction in humans. <i>J Am Heart Assoc<\/i> 2014; 3: e000839.","DOI":"10.1161\/JAHA.114.000839"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38. Verkade MA, van Druningen CJ, Vaessen LM, Hesselink DA, Weimar W, Betjes MG. Functional impairment of monocyte-derived dendritic cells in patients with severe chronic kidney disease. <i>Nephrol Dial Transplant<\/i> 2007; 22: 128\u2013138.","DOI":"10.1093\/ndt\/gfl519"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Anzai A, Anzai T, Naito K, Kaneko H, Mano Y, Jo Y, et al. Prognostic significance of acute kidney injury after reperfused ST-elevation myocardial infarction: Synergistic acceleration of renal dysfunction and left ventricular remodeling. <i>J Card Fail<\/i> 2010; 16: 381\u2013389.","DOI":"10.1016\/j.cardfail.2009.12.020"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Ishige I, Usui Y, Takemura T, Eishi Y. Quantitative PCR of mycobacterial and propionibacterial DNA in lymph nodes of Japanese patients with sarcoidosis. <i>Lancet<\/i> 1999; 354: 120\u2013123.","DOI":"10.1016\/S0140-6736(98)12310-3"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Arai T, Inoue Y, Eishi Y, Yamamoto S, Sakatani M. Propionibacterium acnes in granulomas of a patient with necrotising sarcoid granulomatosis. <i>Thorax<\/i> 2008; 63: 90\u201391.","DOI":"10.1136\/thx.2006.077008"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Chen ES, Moller DR. Etiologies of sarcoidosis. <i>Clin Rev Allergy Immunol<\/i> 2015; 49: 6\u201318.","DOI":"10.1007\/s12016-015-8481-z"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Asakawa N, Uchida K, Sakakibara M, Omote K, Noguchi K, Tokuda Y, et al. Immunohistochemical identification of Propionibacterium acnes in granuloma and inflammatory cells of myocardial tissues obtained from cardiac sarcoidosis patients. <i>PLoS One<\/i> 2017; 12: e0179980.","DOI":"10.1371\/journal.pone.0179980"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Honda Y, Nagai T, Ikeda Y, Sakakibara M, Asakawa N, Nagano N, et al. Myocardial immunocompetent cells and macrophage phenotypes as histopathological surrogates for diagnosis of cardiac sarcoidosis in Japanese. <i>J Am Heart Assoc<\/i> 2016; 5: e004019.","DOI":"10.1161\/JAHA.116.004019"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Ardehali H, Howard DL, Hariri A, Qasim A, Hare JM, Baughman KL, et al. A positive endomyocardial biopsy result for sarcoid is associated with poor prognosis in patients with initially unexplained cardiomyopathy. <i>Am Heart J<\/i> 2005; 150: 459\u2013463.","DOI":"10.1016\/j.ahj.2004.10.006"},{"key":"46","unstructured":"46. Diagnostic standard and guidelines for sarcoidosis. <i>Jpn J Sarcoidosis Granulomatous Disorders<\/i> 2007; 27: 89\u2013102."},{"key":"47","unstructured":"47. Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, et al. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. <i>Sarcoidosis Vasc Diffuse Lung Dis<\/i> 2014; 31: 19\u201327."},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Kuhl U, Seeberg B, Schultheiss HP, Strauer BE. Immunohistological characterization of infiltrating lymphocytes in biopsies of patients with clinically suspected dilated cardiomyopathy. <i>Eur Heart J<\/i> 1994; 15: 62\u201367.","DOI":"10.1093\/eurheartj\/15.suppl_C.62"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Wojnicz R, Nowalany-Kozielska E, Wojciechowska C, Glanowska G, Wilczewski P, Niklewski T, et al. Randomized, placebo-controlled study for immunosuppressive treatment of inflammatory dilated cardiomyopathy: Two-year follow-up results. <i>Circulation<\/i> 2001; 104: 39\u201345.","DOI":"10.1161\/01.CIR.104.1.39"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Maisch B, Richter A, Sandmoller A, Portig I, Pankuweit S; Network B-HF. Inflammatory dilated cardiomyopathy (DCMI). <i>Herz<\/i> 2005; 30: 535\u2013544.","DOI":"10.1007\/s00059-005-2730-5"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Nakayama T, Sugano Y, Yokokawa T, Nagai T, Matsuyama TA, Ohta-Ogo K, et al. Clinical impact of the presence of macrophages in endomyocardial biopsies of patients with dilated cardiomyopathy. <i>Eur J Heart Fail<\/i> 2017; 19: 490\u2013498.","DOI":"10.1002\/ejhf.767"},{"key":"52","doi-asserted-by":"crossref","unstructured":"52. Imanaka-Yoshida K. Tenascin-C in cardiovascular tissue remodeling: From development to inflammation and repair. <i>Circ J<\/i> 2012; 76: 2513\u20132520.","DOI":"10.1253\/circj.CJ-12-1033"},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Yokokawa T, Sugano Y, Nakayama T, Nagai T, Matsuyama TA, Ohta-Ogo K, et al. Significance of myocardial tenascin-C expression in left ventricular remodelling and long-term outcome in patients with dilated cardiomyopathy. <i>Eur J Heart Fail<\/i> 2016; 18: 375\u2013385.","DOI":"10.1002\/ejhf.464"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Hamatani Y, Ishibashi-Ueda H, Nagai T, Sugano Y, Kanzaki H, Yasuda S, et al. Pathological investigation of congenital bicuspid aortic valve stenosis, compared with atherosclerotic tricuspid aortic valve stenosis and congenital bicuspid aortic valve regurgitation. <i>PLoS One<\/i> 2016; 11: e0160208.","DOI":"10.1371\/journal.pone.0160208"},{"key":"55","doi-asserted-by":"crossref","unstructured":"55. Weintraub NL. Understanding abdominal aortic aneurysm. <i>N Engl J Med<\/i> 2009; 361: 1114\u20131116.","DOI":"10.1056\/NEJMcibr0905244"},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. Kadoglou NP, Liapis CD. Matrix metalloproteinases: Contribution to pathogenesis, diagnosis, surveillance and treatment of abdominal aortic aneurysms. <i>Curr Med Res Opin<\/i> 2004; 20: 419\u2013432.","DOI":"10.1185\/030079904125003143"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Choke E, Cockerill G, Wilson WR, Sayed S, Dawson J, Loftus I, et al. A review of biological factors implicated in abdominal aortic aneurysm rupture. <i>Eur J Vasc Endovasc Surg<\/i> 2005; 30: 227\u2013244.","DOI":"10.1016\/j.ejvs.2005.03.009"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Thompson MM, Jones L, Nasim A, Sayers RD, Bell PR. Angiogenesis in abdominal aortic aneurysms. <i>Eur J Vasc Endovasc Surg<\/i> 1996; 11: 464\u2013469.","DOI":"10.1016\/S1078-5884(96)80183-3"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Kaneko H, Anzai T, Horiuchi K, Kohno T, Nagai T, Anzai A, et al. Tumor necrosis factor-alpha converting enzyme is a key mediator of abdominal aortic aneurysm development. <i>Atherosclerosis<\/i> 2011; 218: 470\u2013478.","DOI":"10.1016\/j.atherosclerosis.2011.06.008"},{"key":"60","doi-asserted-by":"crossref","unstructured":"60. Kohno T, Anzai T, Kaneko H, Sugano Y, Shimizu H, Shimoda M, et al. High-mobility group box 1 protein blockade suppresses development of abdominal aortic aneurysm. <i>J Cardiol<\/i> 2012; 59: 299\u2013306.","DOI":"10.1016\/j.jjcc.2012.01.007"}],"container-title":["Circulation Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/3\/82_CJ-18-0063\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T11:04:05Z","timestamp":1570705445000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/circj\/82\/3\/82_CJ-18-0063\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1253\/circj.cj-18-0063","relation":{},"ISSN":["1346-9843","1347-4820"],"issn-type":[{"value":"1346-9843","type":"print"},{"value":"1347-4820","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}